|
|
|
40
|
58811
|
GLUCOBAY 50MG TAB (BSP/COL) ACARBOSE
|
ACARBOSE
|
GLUCOBAY
|
84'S
|
C
|
18.40
|
0.22
|
TABLET
|
0
|
TAB
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
682002
|
ALPHA GLUCOSIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
58811
|
GLUCOBAY 50MG TAB (BSP) ACARBOSE (C)
|
ACARBOSE
|
GLUCOBAY
|
84'S
|
C
|
18.4
|
0.2191
|
TAB
|
180
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
B
|
682002
|
ALPHA GLUCOSIDASE INHIBITORS
|
2024-04-01
|
2024-07-25
|
|
ORAL
|
6
|
ALPHA GLUCOSIDASE INHIBITORS
|
2024-06-13
|
|
|
|
40
|
58816
|
GLUCOBAY 50MG TAB (BSP/AHI) ACARBOSE
|
ACARBOSE
|
GLUCOBAY
|
84'S
|
C
|
18.40
|
0.22
|
TABLET
|
0
|
TAB
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
682002
|
ALPHA GLUCOSIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
40
|
5881J
|
ACARBOSE 50MG TAB (RYV/ATB)
|
ACARBOSE
|
ACARBOSE
|
90'S
|
C
|
16.17
|
0.18
|
TABLET
|
180
|
TAB
|
RYV
|
RYVIS PHARMA PVT. LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
682002
|
ALPHA GLUCOSIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
42
|
5881N
|
GLUCAR 50MG TAB (GLP) ACARBOSE (C)
|
ACARBOSE
|
GLUCAR
|
100'S
|
C
|
1.71
|
0.02
|
TAB
|
180
|
BLIS
|
GLP
|
GLENMARK PHARMACEUTICALS LTD
|
STO
|
BRYDEN STOKES LTD
|
B
|
682002
|
ALPHA GLUCOSIDASE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ALPHA GLUCOSIDASE INHIBITORS
|
|
|
|
|
40
|
58821
|
GLUCOBAY 100MG TAB (BSP/COL) ACARBOSE
|
ACARBOSE
|
GLUCOBAY
|
90'S
|
C
|
35.77
|
0.40
|
TABLET
|
0
|
TAB
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
682002
|
ALPHA GLUCOSIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
58821
|
GLUCOBAY 100MG TAB (BSP) ACARBOSE (C)
|
ACARBOSE
|
GLUCOBAY
|
90'S
|
C
|
35.77
|
0.3975
|
TAB
|
90
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
B
|
682002
|
ALPHA GLUCOSIDASE INHIBITORS
|
2024-04-01
|
2024-07-25
|
|
ORAL
|
6
|
ALPHA GLUCOSIDASE INHIBITORS
|
2024-06-13
|
|
|
|
40
|
58824
|
GLUCOBAY 100MG TAB (BSP/AHI) ACARBOSE
|
ACARBOSE
|
GLUCOBAY
|
90'S
|
C
|
35.77
|
0.40
|
TABLET
|
0
|
TAB
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
682002
|
ALPHA GLUCOSIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
58824
|
GLUCOBAY 100MG TAB (BSP) ACARBOSE (C)
|
ACARBOSE
|
GLUCOBAY
|
90'S
|
C
|
35.77
|
0.3975
|
TAB
|
90
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
682002
|
ALPHA GLUCOSIDASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ALPHA GLUCOSIDASE INHIBITORS
|
|
|
|
|
40
|
5882G
|
ACARBOSE 100MG TAB (LDP/AHI)
|
ACARBOSE
|
ACARBOSE
|
84'S
|
C
|
24.06
|
0.29
|
TABLET
|
0
|
TAB
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
682002
|
ALPHA GLUCOSIDASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|